Variations of tumor necrosis factor-α, leptin and adiponectin in mid-trimester of gestational diabetes mellitus

被引:76
作者
Gao Xue-lian [1 ]
Yang Hui-xia [1 ]
Zhao Yi [1 ]
机构
[1] Peking Univ, Dept Obstet & Gynecol, Hosp 1, Beijing 100034, Peoples R China
关键词
diabetes mellitus; gestational; adiponectin; leptin; tumor necrosis factor-alpha;
D O I
10.1097/00029330-200804020-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Many cytokines have been found to increase the insulin resistance during pregnancy complicated by glucose metabolism disorder. This study aimed to investigate which comes first, the changes of some cytokines or the abnormal glucose metabolism. Methods This nested case-control study was undertaken from January 2004 to March 2005. Twenty-two women with gestational diabetes mellitus (GDM), 10 with gestational impaired glucose tolerance (GIGT), and 20 healthy pregnant women were chosen from the women who had visited the antenatal clinics and had blood samples prospectively taken and kept during their visit. The levels of tumor necrosis factor-alpha (TNF-alpha), leptin and adiponectin were determined. One-way ANOVA analysis and bivariate correlation analysis were used to assess the laboratory results and their relationship with body mass index (BMI). Results Women with GDM have the highest values of TNF-alpha and leptin and the lowest value of adiponectin compared with those with GIGT and the healthy controls (P<0.01) at 14-20 weeks of gestation. This was also found when these women progressed to 24-32 weeks. The significantly increased levels of TNF-alpha and leptin and the decreased level of adiponectin were found at the different periods of gestation within the same group. Positive correlation was shown between the levels of TNF-alpha and leptin at the two periods of gestation with the BMI at 14-20 weeks, while adiponectin was negatively correlated (P<0.05). Conclusions The concentrations of TNF-alpha, leptin and adiponectin may change before the appearance of the abnormal glucose level during pregnancy. Further studies are required to verify the mechanism of this alteration and whether the three cytokines can be predictors for GDM at an early stage of pregnancy.
引用
收藏
页码:701 / 705
页数:5
相关论文
共 31 条
[1]   Relationship between plasma renin profile and leptinaemia in patients with essential hypertension [J].
Adamczak, M ;
Kokot, F ;
Wiecek, A .
JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (08) :503-509
[2]   Modulation of adipokines and cytokines in gestational diabetes and macrosomia [J].
Ategbo, J. -M. ;
Grissa, O. ;
Yessoufou, A. ;
Hichami, A. ;
Dramane, K. L. ;
Moutairou, K. ;
Miled, A. ;
Grissa, A. ;
Jerbi, M. ;
Tabka, Z. ;
Khan, N. A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10) :4137-4143
[3]   Placental leptin receptor isoforms in normal and pathological pregnancies [J].
Challier, J ;
Galtier, M ;
Bintein, T ;
Cortez, A ;
Lepercq, J ;
Hauguel-de Mouzon, S .
PLACENTA, 2003, 24 (01) :92-99
[4]   Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study [J].
Clausen, T ;
Burski, TK ;
Oyen, N ;
Godang, K ;
Bollerslev, J ;
Henriksen, T .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (06) :887-894
[5]   Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus [J].
Coughlan, MT ;
Oliva, K ;
Georgiou, HM ;
Permezel, JMH ;
Rice, GE .
DIABETIC MEDICINE, 2001, 18 (11) :921-927
[6]  
Craigo SD, 2005, MED COMPLICATIONS PR, P41
[7]  
CUNNINGHAM FG, 2005, WILLIAMS OBSTET, P127
[8]  
HOD M, 2003, TXB DIABETES PREGNAN, P32
[9]   Adipocytokines and breast cancer risk [J].
Hou Wei-kai ;
Xu Yu-xin ;
Yu Ting ;
Zhang Li ;
Zhang Wen-wen ;
Fu Chun-li ;
Sun Yu ;
Wu Qing ;
Chen Li .
CHINESE MEDICAL JOURNAL, 2007, 120 (18) :1592-1596
[10]   TNF-α is a predictor of insulin resistance in human pregnancy [J].
Kirwan, JP ;
Hauguel-De Mouzon, S ;
Lepercq, J ;
Challier, JC ;
Huston-Presley, L ;
Friedman, JE ;
Kalhan, SC ;
Catalano, PM .
DIABETES, 2002, 51 (07) :2207-2213